VerifiedBiotechnology Research· Founded 2020

Synox Therapeutics

SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.

7-day free trial · no credit card

Ireland27(1 to 10)2020synoxtherapeutics.com LinkedIn

Verified contacts

19

available on Kipplo

LinkedIn employees

27

1 to 10 range

Open roles

—

no listings

Distinct roles

12

indexed titles

Tech stack

2

tools in use

Monthly traffic

37

organic / mo

Sign up free to see all 19 verified contacts at Synox Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

19 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 19 verified contacts

Top roles at Synox Therapeutics

12 distinct titles indexed · top 10 shown.

2senior vice president finance and operations
1board member
1chief executive officer
1chief technology officer
1cmc technical lead
1executive assistant
1management accountant
1rallybio
1secretome therapeutics
1senior clinical trial manager
+2more titles

Sign up to unlock all 19 contacts at Synox Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 19 verified contacts at Synox Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Synox Therapeutics | Kipplo Discover